Clinical Trials Directory

Trials / Unknown

UnknownNCT04913454

CLearing Alzheimer's Disease Molecular Pathology Without Medications

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University Hospital, Geneva · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Accepted

Summary

According to the most popular pathophysiological models of Alzheimer's disease, the amyloid hypothesis, amyloid deposition is the causative event triggering a chain of other downstream events which finally lead to Alzheimer's disease and dementia. In mouse models of Alzheimer's disease, 40 Hz multi-sensory (auditory and visual) stimulation was able to reduce the number and size of amyloid plaques throughout cortex and improve cognitive performance. The primary objective of this study is to assess whether an intervention consisting of 40 Hz multi-sensory (auditory and visual) stimulation is able to reduce the amyloid load in non-demented amyloid-positive individuals. As secondary objectives, the investigators will assess whether such intervention is able to: * improve the brain electrical activity, * improve or slow down the worsening of Alzheimer's blood-based biomarkers, * improve or slow down the worsening of cognition.

Conditions

Interventions

TypeNameDescription
OTHER40 Hz multi-sensory (auditory + visual) stimulation and cognitive training40 Hz multi-sensory (auditory + visual) stimulation and cognitive training (1 hour/day, per 5 days/week, for a total of 8 weeks)
OTHERCognitive trainingCognitive training (1 hour/day, per 5 days/week, for a total of 8 weeks)

Timeline

Start date
2021-08-01
Primary completion
2022-06-30
Completion
2022-07-31
First posted
2021-06-04
Last updated
2021-06-04

Source: ClinicalTrials.gov record NCT04913454. Inclusion in this directory is not an endorsement.